1Wang H, Vishnubbakat JM, Bloom O, et al. Proinflammatory cytokines( tumor necrosis factor and interleukin 1 ) stimulate release of high mobility group protein- 1 by pituieytes[J].Surgery, 1999,126(2) :389- 392.
2Deitch EA. Animal models of sepsis and shock: a review and lessons leamed[l]. Shoek,1998,9(1):1 - 11.
3Oberholzer A, Oberholzet C, Moldawer LL. Cytokine signaling-regulation of the immune redpondr in normal and critically ill states[ J].Crit Care Med.2000.28(4 Suppl):N3- 12.
4Keane J, Gershon S, Wise RP, et al. Tuberculosis associated with infliximab a tumor necrosis factor alpha - neutralizing agent[J]. N Engl J Med,2001,345(15) : 1098- 1104.
5Arbour NC, Lorenz E, Schutte BC, et al.TLR4 mutations are associated with endotoxin hyporesponsiveness in humans[J]. Nat Genet, 2000,25(2) : 187 - 191.
7Abbas AK, Murphy KM, Sher A. Functional diversity of helper T lymphocytes [J]. Nature. 1996. 383(6603) :797 - 793.
8Lederer JA, Rodrick ML, Mannick JA. The effects of injury on theadaptive inmmune response[J]. Shock,1999,11(3):153- 159.
9Gogos CA, Drosou E, Bassaris HP, et al. Pro- versus antiinflammatory cytokine profile in patients with severe sepsis: a marker for prognosis and future therapeutic opticcs[J]. J Infect Dis,2O00,181( 1):176- 180.
10Heidecke CD, Hensler T, Weighardt H, et al. Selective ddects of T lymphocyte function in patients with lethal intraabdominal infection[ J].Am J Surg, 1999,178(4) :288 - 292.
4Lang JD, Matute-Bello G. Lymphoeytes, apoptosis and sepsis: making the jump from mice to humans. Critical Care, 2009, 13 (1) : 109.
5Maher SG, Condron CE, Bouchier-Hayes DJ, et al. Taurine attenuates CD3/interleukin-2-induced T cell apoptosis in an in vitro model of activation-induced cell death (AICD) . Clin Exp Immunol, 2005, 139(2) : 279-286.
6Shimaoka M, Park EJ. Advances in understanding sepsis. Eur J Anaesthesiol Suppl, 2008, 42 : 146-153.
7Prass K, Meisel C, Hoflich C, et al. Stroke-induced immunodeficiency promotes spontaneous bacterial infections and is mediated by sympathetic activation reversal by poststroke T helper cell type 1-like immunostimulation. J Exp Med, 2003, 198(5) : 725-736.
8Annane D, Cavaillon JM. Corticosteroids in sepsis: from bench to beside? Shock, 2003, 20(3): 197-207.
9Maher S, Toomey D, Condron C, et al. Activation-induced cell death: the controversial role of Fas and Fas ligand in immune privilege and tumour counterattack. Immunol Cell Biol, 2002, 80 (2) : 131-137.
10Messaris E, Memos N, Chatzigianni E, et al. Time-dependent mitochondrial-mediated programmed neuronal cell death prolongs survival in sepsis. Crit Care Med, 2004, 32(8) : 1764-1770.
